The same absorbent brief is a Class I device in both countries, and that is where the similarity stops. Canada reaches Class I through the classification rules in Schedule 1 of the Medical Devices Regulations, which sweep non-invasive devices that are not caught by a higher rule into the lowest class. The United States names the product in 21 CFR 876.5920 and then attaches a specific set of exemptions. For a supplier shipping to both markets, or a provider group standardising a specification across sites, the differences that matter are the premarket route, the quality system obligation, the labelling content, and the language rule.
This page compares the two regimes item by item and then holds the volume forecast constant to show what does not change. The products in scope are the absorbent briefs themselves, for example a day comfort adult incontinence brief and a night plus overnight brief.
Quick facts on adult brief regulation in Canada and the United States
- Canada classifies a non-invasive device that is not caught by a higher rule as Class I under Rule 7(1) of Schedule 1 to the Medical Devices Regulations.
- Rule 4(2) of the same schedule keeps a device used as a mechanical barrier, for compression, or for absorption of exudations in Class I.
- Class I devices do not need a medical device licence in Canada, but importers and distributors need an establishment licence under section 44.
- The United States names the product in 21 CFR 876.5920 as a Class I device and exempts it from premarket notification subject to 876.9.
- American labelling content comes from the device regulation and general controls; Canadian labelling content is listed in section 21 of the Medical Devices Regulations.
- Canadian labelling must be in English or French, and in both languages when the device is sold to the general public.
How does Health Canada classify an adult incontinence brief?
The Medical Devices Regulations classify devices by rule rather than by product name. Rule 4 covers non-invasive devices that come into contact with injured skin and sets them in Class II, while Rule 4(2) keeps a device intended to be used as a mechanical barrier, for compression, or for absorption of exudations in Class I. Rule 7(1) then catches all other non-invasive devices and places them in Class I unless they are intended to act as a calibrator or tester for another device, or to be connected to an active device of Class II or higher.
An absorbent brief is a non-invasive device that does not enter the body, does not contact injured skin, and does not modify the composition of body fluids. On the text of Schedule 1 it therefore sits in Class I. That classification has a specific consequence in Canada: Class I devices do not require a medical device licence, which is why no licence number appears on the package. The obligation that does apply is the establishment licence, because section 44 prohibits importing or selling a medical device without one, subject to exemptions for retailers, health care facilities and manufacturers that meet the stated conditions.
How does the FDA classify the same product?
The American regulation is a product-specific listing. 21 CFR 876.5920 describes a protective garment for incontinence as a device consisting of absorbent padding and a fluid barrier, intended to protect an incontinent patient's garment from the patient's excreta, and expressly excludes infant diapers. It classifies the device as Class I, exempts it from premarket notification procedures in subpart E of part 807 subject to the limitations in 876.9, and exempts it from the quality management system regulation except for requirements concerning records and complaint files under 820.35.
Three practical differences follow from that wording. There is no 510(k) number to quote, so a request for one signals a specification sheet written by someone who has not read the section. The quality system obligation is narrowed but not erased, because records and complaint files survive the exemption. And the exemption is conditional on 876.9, which limits exemption where the device is for a use that presents a potential unreasonable risk of illness or injury.
Where do the two regimes differ?
The differences cluster in five places: how classification is reached, what premarket evidence is filed, what quality system obligations survive, what must appear on the label, and what language the label must use. None of them change the product's clinical function, and all of them change the paperwork a supplier must be able to produce.
| Item | Canada | United States |
|---|---|---|
| Classification route | Schedule 1 rules, with Rule 7(1) catching other non-invasive devices | Product-specific listing in 21 CFR 876.5920 |
| Class | Class I on the text of the rules | Class I |
| Premarket submission | No device licence for Class I; no premarket filing | Exempt from 510(k) subject to 21 CFR 876.9 |
| Quality system | No licence condition for a Class I device; establishment licence conditions apply to the importer or distributor | Exempt from the quality management system regulation except records and complaint files under 820.35 |
| Establishment obligation | Establishment licence under section 44 for import or sale, with listed exemptions | Establishment registration and device listing |
| Label content | Listed items in section 21(1), including name, manufacturer, identifier, contents, directions and storage conditions | General controls and the device labelling requirements that apply to the product |
| Control number on the label | Required only for Class III or IV devices, so not applicable here | No lot number requirement of this kind for a Class I exempt device |
| Expiry date on the label | Required if the device has an expiry date, determined by the manufacturer | No federal requirement of general application for this device type |
| Language | English or French at minimum, with both required for general-public sale for specified items | English |
What has to be on the label in each country?
Canada lists the required label content in section 21(1) of the Medical Devices Regulations, and the list is long enough that a supplier should keep it open when designing artwork. It includes the name of the device, the name and address of the manufacturer, the identifier of the device, an indication of what the package contains where the contents are not readily apparent, the word sterile where the manufacturer intends the device to be sold sterile, the expiry date if the device has one, the medical conditions and purposes where not self-evident, the directions for use, and any special storage conditions. The information must be legible, permanent and prominent, in terms easily understood by the intended user.
The language rule is the part most often missed by an American supplier. Section 23(1) requires the section 21(1) information to be in English or French as a minimum, and section 23(2) requires the manufacturer to make directions for use available in the other official language on request. Section 23(3) goes further for devices sold to the general public: the information required by paragraph 21(1)(a) and paragraphs 21(1)(e) to (j) must be in both English and French. A brief sold through a pharmacy to a family caregiver is a general-public sale, which is why bilingual packaging appears in that channel rather than in the professional one.
Does the volume forecast change across the border?
No. The forecast is driven by care, not by device class. In both countries the number of briefs a facility consumes is residents multiplied by incontinent share, multiplied by changes per day, multiplied by days. 42 CFR 483.25(e) in the United States and provincial care standards in Canada both make the assessment the anchor, and neither attaches a quantity to the device. A 100-bed facility with 55 frequently or always incontinent residents changed four times a day needs about 6,700 briefs a month in Ontario and in Ohio alike.
What does change is procurement documentation. A Canadian purchaser should be able to name the establishment licence holder for the product it buys, and should check that the label language matches the channel it sells through. An American purchaser should expect an establishment registration and listing rather than a clearance letter, and should route product complaints to the manufacturer's complaint file, which survives the quality system exemption.
| Procurement check | Canada | United States |
|---|---|---|
| Licence or registration to request | Establishment licence of the importer or distributor | Establishment registration and device listing |
| Premarket document | None for Class I | None; 510(k) exemption applies subject to 876.9 |
| Label review | Section 21(1) items, plus section 23 language rule | Product labelling and general controls |
| Complaint route | Supplier's quality process and the establishment licence conditions | Manufacturer's complaint file under 820.35 |
| Forecast method | Census, assessment data, change frequency | Census, MDS coding, change frequency |
Which specification fields change between Canada and the United States?
The field list itself does not change. Product identity, configuration, size basis, absorbency basis, case pack count and the record-keeping trail are set out once, in the US nursing home procurement specification sheet, and a Canadian sheet can work from the same twelve fields without rebuilding them.
Three of those fields take a different answer on each side of the border. The licence or registration field asks for the establishment licence number held by the importer or distributor in Canada, and for establishment registration and device listing in the United States. The premarket document field stays empty on both: a Class I device has no licence number in Canada, and a device exempt under 21 CFR 876.5920 has no 510(k) number, so a sheet that demands either tells a reviewer the template was copied rather than read. The label language field carries English or French in Canada, with both languages required for specified items sold to the general public, and English in the United States, which changes the artwork column rather than the product column.
Standardising a brief specification across Canadian and US sites? Send the sizes, absorbency bands and label language versions in use, and the answer will map the documentation each market expects. Open an institutional account enquiry. Reselling? become a distributor.
Count sheets and stock logs for a storeroom are in the compliance log centre.
Related reading
- How many briefs a US nursing home uses per resident per month
- How US home health agencies size briefs for bedbound patients
- Sizing bedbound patients: Health Canada rules compared with FDA requirements
Sources and version notes
- Medical Devices Regulations, SOR/98-282, consolidated text, including Schedule 1 and sections 21, 23 and 44 — checked 14 November 2026.
- 21 CFR 876.5920, protective garment for incontinence — checked 14 November 2026.
- 21 CFR 876.9, limitations of exemptions from section 510(k) — checked 14 November 2026.
- 21 CFR 820.35, records and complaint files — checked 14 November 2026.
- 42 CFR 483.25, quality of care, paragraph (e) on incontinence — checked 14 November 2026.
- CMS State Operations Manual, Appendix PP, F690 — checked 14 November 2026.
- Electronic Code of Federal Regulations, 21 CFR part 876 — checked 14 November 2026.
- LOINC answer list LL663-6, MDSv3 H0300 urinary continence — checked 14 November 2026.
Frequently Asked Questions
Are adult briefs Class I devices in Canada?
On the text of Schedule 1, a non-invasive device that is not caught by a higher rule falls to Class I under Rule 7(1), and Rule 4(2) keeps devices used for absorption of exudations in Class I. Class I devices do not need a medical device licence.
Do Canadian adult briefs need a device licence number on the label?
No. Class I devices are not licensed, and the control number required by section 21(1)(d) applies only to Class III and IV devices.
Does an importer need a licence to sell briefs in Canada?
Yes. Section 44 prohibits importing or selling a medical device without an establishment licence, subject to exemptions that include retailers, health care facilities and manufacturers meeting stated conditions.
Must the label be bilingual in Canada?
Section 23(1) requires English or French as a minimum. Section 23(3) requires both languages for specified label items when the device is sold to the general public.
Is a 510(k) required for adult briefs in the United States?
No. 21 CFR 876.5920 exempts the device from premarket notification subject to the limitations in 876.9, and exempts it from the quality management system regulation except for records and complaint files under 820.35.
This article describes legislation and regulation as published at the time of writing and does not reproduce it in full. Classification of a specific product depends on its intended use and labelling; confirm with the manufacturer or a regulatory professional. This article is for information and is not legal advice. CliniEco Medical distributes medical consumables under MDEL #35334.